{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T08:33:05Z","timestamp":1772613185610,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T00:00:00Z","timestamp":1431907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0126767","type":"journal-article","created":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T19:48:53Z","timestamp":1431978533000},"page":"e0126767","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Determinants of Reduced Antiplatelet Effect of Aspirin in Patients with Stable Coronary Artery Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Sanne B\u00f8jet","family":"Larsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Lerkevang","family":"Grove","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00f8s","family":"Neergaard-Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"W\u00fcrtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steen Dalby","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,5,18]]},"reference":[{"issue":"9678","key":"ref1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1586\/erc.12.144","article-title":"Identifying determinants of variability to tailor aspirin therapy","volume":"11","author":"B Rocca","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"15","key":"ref3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/archinte.167.15.1593","article-title":"Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis","volume":"167","author":"JD Snoep","year":"2007","journal-title":"Arch Intern Med"},{"issue":"7637","key":"ref4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/bmj.39430.529549.BE","article-title":"Aspirin &quot;resistance&quot; and risk of cardiovascular morbidity: systematic review and meta-analysis","volume":"336","author":"G Krasopoulos","year":"2008","journal-title":"BMJ"},{"issue":"8","key":"ref5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3109\/07853890.2011.605388","article-title":"A contemporary viewpoint on &apos;aspirin resistance&apos;","volume":"44","author":"N Kuzniatsova","year":"2012","journal-title":"Ann Med"},{"issue":"33","key":"ref6","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.2174\/138161212803251925","article-title":"Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance","volume":"18","author":"M Wurtz","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/clc.22031","article-title":"Aspirin Resistance: Current Status and Role of Tailored Therapy","volume":"35","author":"J Grinstein","year":"2012","journal-title":"Clin Cardiol"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1160\/TH12-01-0026","article-title":"Increased platelet aggregation and serum thromboxane levels inaspirin-treatedpatients with prior myocardial infarction","volume":"108","author":"SB Larsen","year":"2012","journal-title":"Thromb Haemost"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1160\/TH12-09-0666","article-title":"Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease","volume":"109","author":"SB Larsen","year":"2013","journal-title":"Thromb Haemost"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jcin.2010.05.014","article-title":"Patients with previous definite stent thrombosis have a reduced antiplatelet effect of aspirin and a larger fraction of immature platelets","volume":"3","author":"M Wurtz","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.thromres.2011.07.019","article-title":"Influence of renal function and platelet turnover on the antiplatelet effect of aspirin","volume":"129","author":"M Wurtz","year":"2012","journal-title":"Thromb Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2147\/CLEP.S10190","article-title":"Existing data sources for clinical epidemiology: The Western Denmark Heart Registry","volume":"2","author":"M Schmidt","year":"2010","journal-title":"Clin Epidemiol"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1160\/TH09-08-0527","article-title":"A comparison of platelet function tests and thromboxane metabolites to evaluate aspirin response in healthy individuals and patients with coronary artery disease","volume":"103","author":"EL Grove","year":"2010","journal-title":"Thromb Haemost"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/eurheartj\/ehn562","article-title":"Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology","volume":"30","author":"W Kuliczkowski","year":"2009","journal-title":"Eur Heart J"},{"issue":"1","key":"ref15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncpcardio0728","article-title":"Drug insight: aspirin resistance\u2014fact or fashion?","volume":"4","author":"C Patrono","year":"2007","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2011.08.019","article-title":"Platelet aggregation is dependent on platelet count in patients with coronary artery disease","volume":"129","author":"M Wurtz","year":"2012","journal-title":"Thromb Res"},{"issue":"1","key":"ref17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijcard.2009.01.037","article-title":"Platelet count, not oxidative stress, may contribute to inadequate platelet inhibition by aspirin","volume":"143","author":"M Lordkipanidze","year":"2010","journal-title":"Int J Cardiol"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.thromres.2006.12.020","article-title":"Prevalence and biologic profile of aspirin resistance in patients with angiographically proven coronary artery disease","volume":"120","author":"I Narvaez","year":"2007","journal-title":"Thromb Res"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","article-title":"Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease","volume":"46","author":"AO Maree","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0735-1097(97)00510-X","article-title":"Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease","volume":"31","author":"MI Furman","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11318100-000000000-00000","article-title":"Effect of obesity on the pharmacokinetics of drugs in humans","volume":"49","author":"MJ Hanley","year":"2010","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"ref22","first-page":"930","article-title":"Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy","volume":"99","author":"F Cesari","year":"2008","journal-title":"Thromb Haemost"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1538-7836.2010.04115.x","article-title":"Effect of platelet turnover on whole blood platelet aggregation in patients with coronary artery disease","volume":"9","author":"EL Grove","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0002-8703(85)90005-5","article-title":"Shortened megakaryocyte-platelet regeneration time in young survivors of myocardial infarction","volume":"110","author":"A Hamsten","year":"1985","journal-title":"Am Heart J"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2174\/157016112800812818","article-title":"Antiplatelet therapy in patients with diabetes mellitus","volume":"10","author":"EL Grove","year":"2012","journal-title":"Curr Vasc Pharmacol"},{"issue":"33","key":"ref26","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.2174\/138161212803251916","article-title":"Challenges and perspectives of antiplatelet therapy in patients with diabetes mellitus and coronary artery disease","volume":"18","author":"JL Ferreiro","year":"2012","journal-title":"Curr Pharm Des"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/j.thromres.2010.03.013","article-title":"Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus","volume":"126","author":"SB Mortensen","year":"2010","journal-title":"Thromb Res"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","article-title":"Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control","volume":"113","author":"C Watala","year":"2004","journal-title":"Thromb Res"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1751-7141.2009.00058.x","article-title":"Effect of obesity on platelet reactivity and response to low-dose aspirin","volume":"13","author":"BC Bordeaux","year":"2010","journal-title":"Prev Cardiol"},{"issue":"10","key":"ref30","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/j.1538-7836.2010.03997.x","article-title":"The role of weight and enteric coating on aspirin response in cardiovascular patients","volume":"8","author":"A Peace","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.amjcard.2009.07.015","article-title":"Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention","volume":"104","author":"N Bonello-Palot","year":"2009","journal-title":"Am J Cardiol"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Mayer K, Orban M, Bernlochner I, Braun S, Schulz S, Gross L, et al. Predictors of antiplatelet response to prasugrel during maintenance treatment. Platelets 2014 Jan 16;<italic>In Press<\/italic>.","DOI":"10.3109\/09537104.2013.863857"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"376721","DOI":"10.1155\/2012\/376721","article-title":"Variability in the responsiveness to low-dose aspirin: pharmacological and disease-related mechanisms","volume":"2012","author":"B Rocca","year":"2012","journal-title":"Thrombosis"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.48.2.426","article-title":"Leptin promotes aggregation of human platelets via the long form of its receptor","volume":"48","author":"M Nakata","year":"1999","journal-title":"Diabetes"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.amjcard.2013.03.022","article-title":"Relation of aspirin response to age in patients with stable coronary artery disease","volume":"112","author":"M Vaturi","year":"2013","journal-title":"Am J Cardiol"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/eurheartj\/ehr407","article-title":"High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study","volume":"33","author":"J Silvain","year":"2011","journal-title":"Eur Heart J"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.amjcard.2007.12.038","article-title":"Platelet inhibition by aspirin 81 and 325 mg\/day in men versus women without clinically apparent cardiovascular disease","volume":"101","author":"R Qayyum","year":"2008","journal-title":"Am J Cardiol"},{"issue":"12","key":"ref38","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jama.295.12.1420","article-title":"Sex differences in platelet reactivity and response to low-dose aspirin therapy","volume":"295","author":"DM Becker","year":"2006","journal-title":"JAMA"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.ahj.2004.08.030","article-title":"Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment","volume":"149","author":"I Ikonomidis","year":"2005","journal-title":"Am Heart J"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.amjcard.2006.03.029","article-title":"Frequency of aspirin resistance in a community hospital","volume":"98","author":"A Mirkhel","year":"2006","journal-title":"Am J Cardiol"},{"issue":"3\u20134","key":"ref41","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09537100400020161","article-title":"Can platelet aggregometry be standardized?","volume":"16","author":"HK Breddin","year":"2005","journal-title":"Platelets"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/09537104.2012.698431","article-title":"Effect of different anticoagulants on multiple electrode platelet aggregometry after clopidogrel and aspirin administration in patients undergoing coronary stent implantation: a comparison between citrate and hirudin","volume":"24","author":"HZ Zhang","year":"2013","journal-title":"Platelets"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/09537104.2011.624211","article-title":"Which is the best anticoagulant for whole blood aggregometry platelet function testing? Comparison of six anticoagulants and diverse storage conditions","volume":"23","author":"AF Kaiser","year":"2012","journal-title":"Platelets"},{"issue":"3","key":"ref44","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1055\/s-0038-1647337","article-title":"The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma","volume":"64","author":"T Lindhout","year":"1990","journal-title":"Thromb Haemost"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0126767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,25]],"date-time":"2019-08-25T07:49:31Z","timestamp":1566719371000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0126767"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Sch\u00e4fer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,5,18]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,5,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0126767","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,18]]}}}